Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Bleomycin × Clear all

Sponsor

Conditions

Hodgkin Disease 12 Lymphoma 10 Testicular Neoplasms 2 Teratoma 2 Endodermal Sinus Tumor 2 Testicular Germ Cell Tumor 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Ovarian gynandroblastoma 1 Ovarian Germ Cell Cancer 1 Lymphoma, Follicular 1 HIV Infections 1 Granulosa cell tumor of the ovary 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Embryonal 1 Breast Neoplasms 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 pembrolizumab 1 ioflupane 1 idelalisib 1 aflibercept 1 Water 1 Vertical Dimension 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡